Latest filing published 01 Apr 2024 for YIELD10 BIOSCIENCE, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Anthony J. Sinskey, listed as board member, appears in our data through filings on Yield10 Bioscience, Inc. shares, published by SEC (Form 4). In total, 10 filings cover trades dated from 2 December 2021 to 28 March 2024.
Every open-market trade on record is a purchase: 4 purchases worth €28k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 5 share grants.
The median purchase comes to €6,938. On 1 out of 4 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 1 April 2024 came the latest disclosure, a share grant in Yield10 Bioscience, Inc. The last insider purchase was made public on 17 August 2022, 1,523 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations